The impressive growth in
biologics has attracted top-tier
pharma companies to the
biogenerics arena.
Despite the significant costs
and hurdles expected in
developing and gaining
approval for such products,...
The rise in counterfeit medicines worldwide, with concomitant problems of toxicity, instability and ineffectiveness, is often underestimated...
The pharmaceutical industry is facing a tough road ahead in the future marketplace. Though pharmaceuticals remain the most costeffective healthcare intervention,...
Vaccines play a central role in health protection and advances in biotechnologies now offers numerous novel approaches for vaccine development...
Understanding the solubility behaviour of the drugexcipient complex in a lipid-based drug delivery system will help...
Although conventional freeze drying in vials is still the predominant format, lyophilisation in alternative formats, such as pre-filled syringes,...
This is a case study of how Amgen manages a major electronic Common Technical Document filing. It focusses on tools and processes developed and refined from 2005 to present...
Because R&D productivity is a problem for pharma the partnering opportunities are basically seen in licensing and acquisitions.
India's growing respect and legal / regulatory framework for IPR, favourable economic policies resulting into attractive investment destination and availability of huge talent pool...
In managing Chemistry, Manufacturing and Controls documents, the larger process is involved for electronic regulatory submissions to health authorities...
Alan S Louie
Research Director
Christopher
-Paul Milne
Associate Director
Douglas Meyer
Senior Director
Frank A Jaeger
Director, New Business Development
Georg C Terstappen
Chief Scientific Officer
Kenneth I Kaitin
Director and Professor of Medicine
Laurence Flint
Associate Director
Neil J Campbell
CEO, Mosaigen Inc. and Partner, Endeavour Capital Asia Ltd., USA
Phil Kaminsky
Founder, Center for Biopharmaceutical Operations, University of California, Berkeley, USA
Rustom Mody
Director, Quality and Strategic Research, Intas Biopharmaceuticals
Limited,
India.
Sanjoy Ray
Director, Technology Innovation
Sasikant Misra
Deputy Director, Confederation of Indian Industry, India.
...
10 Feb, 2010
...
9 Feb, 2010
...

16 Feb, 2010
Cardium Announces Agreement With bioRASI to Advance and Broaden Clinic
...
12 Feb, 2010
Malvern Instruments opens third centre of excellence in India
...
10 Feb, 2010
Lung Rx and ImmuneWorks Announce Collaboration in Idiopathic Pulmonary
...

Mar 1 - Mar 4 2010
HIMSS10...
Mar 4 - Mar 5 2010
INTERPHEX Puerto Rico 2010...
Mar 4 - Mar 5 2010
Asia Pharma R&D Leaders 2010...
I have been very impressed with the quality and timeliness of the articles. Each of...
David R. Webb
Vice President, Research
Signal Pharmaceuticals
LLC, A wholly owned
subsidiary of CELGENE, USA
The magazine looked great and there were excellent articles of huge interest.
Dr Iman El-Hariry
Group Director
Oncology MDC, Europe
GlaxoSmithKline, UK